These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 26701665)
1. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer. Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665 [TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence. Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407 [TBL] [Abstract][Full Text] [Related]
3. E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma. Spector ME; Sacco AG; Bellile E; Taylor JMG; Jones T; Sun K; Brown WC; Birkeland AC; Bradford CR; Wolf GT; Prince ME; Moyer JS; Malloy K; Swiecicki P; Eisbruch A; McHugh JB; Chepeha DB; Rozek L; Worden FP Clin Cancer Res; 2017 Jun; 23(11):2723-2729. PubMed ID: 27872102 [No Abstract] [Full Text] [Related]
4. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer. Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197 [TBL] [Abstract][Full Text] [Related]
6. Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma. Hanna GJ; Sridharan V; Margalit DN; La Follette SK; Chau NG; Rabinowits G; Lorch JH; Haddad RI; Tishler RB; Anderson KS; Schoenfeld JD Cancer Biomark; 2017; 19(2):129-136. PubMed ID: 28387659 [TBL] [Abstract][Full Text] [Related]
7. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Anderson KS; Wong J; D'Souza G; Riemer AB; Lorch J; Haddad R; Pai SI; Longtine J; McClean M; LaBaer J; Kelsey KT; Posner M Br J Cancer; 2011 Jun; 104(12):1896-905. PubMed ID: 21654689 [TBL] [Abstract][Full Text] [Related]
8. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Kreimer AR; Clifford GM; Snijders PJ; Castellsagué X; Meijer CJ; Pawlita M; Viscidi R; Herrero R; Franceschi S; Int J Cancer; 2005 Jun; 115(2):329-32. PubMed ID: 15688391 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment. Zhang Y; Waterboer T; Haddad RI; Miles BA; Wentz A; Gross ND; Fakhry C; Quon H; Lorch JH; Gourin CG; Clayburgh D; Misiukiewicz KJ; Richmon JD; Andersen PE; Posner MR; D'Souza G Oral Oncol; 2017 Apr; 67():77-82. PubMed ID: 28351584 [TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma. Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084 [TBL] [Abstract][Full Text] [Related]
11. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx. Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432 [TBL] [Abstract][Full Text] [Related]
12. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study. Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126 [TBL] [Abstract][Full Text] [Related]
13. Markers of HPV infection and survival in patients with head and neck tumors. Koslabova E; Hamsikova E; Salakova M; Klozar J; Foltynova E; Salkova E; Rotnaglova E; Ludvikova V; Tachezy R Int J Cancer; 2013 Oct; 133(8):1832-9. PubMed ID: 23564321 [TBL] [Abstract][Full Text] [Related]
14. Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study. Anderson KS; Gerber JE; D'Souza G; Pai SI; Cheng JN; Alam R; Kesiraju S; Chowell D; Gross ND; Haddad R; Gillison ML; Posner M Oral Oncol; 2015 Aug; 51(8):751-8. PubMed ID: 26094591 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of posttreatment HPV-specific antibodies in patients with oropharyngeal tumors. Simonidesova S; Hamsikova E; Ludvikova V; Klozar J; Vencalek O; Tachezy R J Surg Oncol; 2019 Aug; 120(2):117-124. PubMed ID: 30986340 [TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Lang Kuhs KA; Anantharaman D; Waterboer T; Johansson M; Brennan P; Michel A; Willhauck-Fleckenstein M; Purdue MP; Holcátová I; Ahrens W; Lagiou P; Polesel J; Simonato L; Merletti F; Healy CM; Kjaerheim K; Conway DI; Macfarlane TV; Thomson P; Castellsagué X; Znaor A; Black A; Huang WY; Krogh V; Trichopoulou A; Bueno-de-Mesquita HB; Clavel-Chapelon F; Weiderpass E; Ekström J; Riboli E; Tjønneland A; Sánchez MJ; Travis RC; Hildesheim A; Pawlita M; Kreimer AR Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):683-9. PubMed ID: 25623733 [TBL] [Abstract][Full Text] [Related]
17. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank. Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371 [TBL] [Abstract][Full Text] [Related]
18. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status. Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822 [TBL] [Abstract][Full Text] [Related]
19. Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer. D'Souza G; Clemens G; Troy T; Castillo RG; Struijk L; Waterboer T; Bender N; Pierorazio PM; Best SR; Strickler H; Wiley DJ; Haddad RI; Posner M; Fakhry C Cancer Prev Res (Phila); 2019 Oct; 12(10):689-700. PubMed ID: 31420362 [TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection. Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]